<unk>  (INN, marketing name Orathecin) is an oral topoisomerase inhibitor, developed by SuperGen (now Astex Pharmaceuticals, Inc.; a member of the Otsuka Group).
Rubitecan
Cephem
Clinatec
Mecasermin
Covaxin
Ioxaglic acid
Bempedoic acid
Palifermin